Provided by Tiger Trade Technology Pte. Ltd.

BridgeBio Pharma, Inc.

76.03
-0.5700-0.74%
Volume:869.11K
Turnover:65.83M
Market Cap:14.89B
PE:-21.31
High:76.77
Open:76.20
Low:75.03
Close:76.60
52wk High:93.42
52wk Low:48.78
Shares:195.81M
Float Shares:167.00M
Volume Ratio:0.74
T/O Rate:0.52%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.5686
EPS(LYR):-3.7850
ROE:-1789.67%
ROA:-26.00%
PB:-5.92
PE(LYR):-20.09

Loading ...

BridgeBio Pharma Inc - FDA Not Planning Advisory Committee Meeting for Bbp-418 Application

THOMSON REUTERS
·
May 27

BridgeBio CEO Neil Kumar sells BBIO shares worth $1.73 million

Reuters
·
May 27

BridgeBio Pharma Inc : Raymond James Cuts to Market Perform From Outperform

THOMSON REUTERS
·
May 26

U.S. RESEARCH ROUNDUP-Apollo, Phillips 66, Valero Energy

Reuters
·
May 26

BridgeBio Pharma (BBIO) Gets a Hold from Citi

TIPRANKS
·
May 20

Analysts Offer Insights on Healthcare Companies: BridgeBio Pharma (BBIO) and Cullinan Management (CGEM)

TIPRANKS
·
May 20

BridgeBio Pharma President, CFO Thomas Trimarchi disposes of USD 2.41 million shares

Reuters
·
May 20

BridgeBio director Randal W. Scott sells USD 655,873 in common shares

Reuters
·
May 20

BridgeBio Pharma Initiated at Neutral by Citigroup

Dow Jones
·
May 19

U.S. RESEARCH ROUNDUP-Costco Wholesale, HCA Healthcare, Micron Technology

Reuters
·
May 19

BridgeBio initiated with a Neutral at Citi

TIPRANKS
·
May 19

Stock Track | BridgeBio Pharma Soars 5.02% Intraday on Analyst Bullishness

Stock Track
·
May 14

Analysts Are Bullish on These Healthcare Stocks: BridgeBio Pharma (BBIO), Palisade Bio (PALI)

TIPRANKS
·
May 13

BridgeBio Oncology Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 13

BridgeBio Oncology awards employee stock options for 32,675 shares at $7.66

Reuters
·
May 13

BridgeBio shares have ‘clear path’ to $90s, says JPMorgan

TIPRANKS
·
May 12

BRIEF-Bridgebio Submits NDA To FDA For Encaleret For Individuals Living With ADH1

Reuters
·
May 12

BridgeBio Files New Drug Application for Rare Calcium Disorder Treatment

MT Newswires Live
·
May 12

BridgeBio submits FDA NDA for encaleret to treat autosomal dominant hypocalcemia type 1

Reuters
·
May 12

BridgeBio Submits Nda to FDA for Encaleret for Individuals Living With Adh1

THOMSON REUTERS
·
May 12